IPP Bureau
AstraZeneca India appoints Ram Mudaliar as India lead of their CDI division
By IPP Bureau - January 20, 2022
Ram’s appointment follows the launch of the CDI India division in October 2021.
Novo Nordisk India launches world’s first and only GLP-1 RA, oral semaglutide
By IPP Bureau - January 20, 2022
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
Natco Pharma signs agreement with Medicines Patent Pool
By IPP Bureau - January 20, 2022
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool
By IPP Bureau - January 20, 2022
They will commercialize molnupiravir in the international markets
Max Healthcare to add over 300 beds in NCR ties up with Muthoot Hospitals
By IPP Bureau - January 20, 2022
The hospital will be operated under the name and style of Max Super Speciality Hospital, Dwarka
CliniSys creates world’s largest diagnostics and lab informatics with recent acquisitions
By IPP Bureau - January 19, 2022
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
Lupin ties up with Foncoo of China
By IPP Bureau - January 19, 2022
This is the company’s first partnership arrangement in China
Lonza, Forbion, and BioGeneration to focus on manufacturing of small molecules
By IPP Bureau - January 19, 2022
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
China approves MIOK Keratoprosthesis’ artificial cornea
By IPP Bureau - January 19, 2022
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
By IPP Bureau - January 19, 2022
These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Experts highlight positives of yoga in coping with Covid waves
By IPP Bureau - January 19, 2022
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
Healthcare for seniors an opportunity for service providers
By IPP Bureau - January 19, 2022
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences
By IPP Bureau - January 19, 2022
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
ICMR approves Krivida Novus RT-PCR kit
By IPP Bureau - January 19, 2022
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Menarini Diagnositcs PCR kit identifies Omicron variant
By IPP Bureau - January 18, 2022
It provides Covid-19 detection and Omicron surveillance in less than two hours
